A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

This study is currently recruiting participants.
Verified July 2013 by PCI Biotech AS
Sponsor:
Information provided by (Responsible Party):
PCI Biotech AS
ClinicalTrials.gov Identifier:
NCT01900158
First received: May 15, 2013
Last updated: July 22, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)